Stock screenerAll disclosures →
EDGAR →
CVS
Conviction 93HealthcareScan · Thu, Jun 25, 2026CVS$104.70+2.77%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
4
2
Vol MA14 9.64M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +0.00%· 1 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price104.70
Change+2.77%
Gap+0.63%
Rel volume1.63×
Avg volume9.12M
Avg $ vol893.61M
SMA 2097.46
SMA 5090.66
SMA 20080.81
Price vs 50+15.49%
Price vs 200+29.55%
MA stackbullish
50/200 cross—
Supertrendup · 95.97
RSI (14)73
MACD hist0.17
MACD crossbull · 3d
Stoch %K / %D98 / 91
ADX (14)42
+DI / −DI38 / 13
RSI divergenceBearish
MACD divergenceBearish
ATR %+2.40%
ADR %2.42%
52w high104.70
52w low58.75
From 52w high+0.00%
Above 52w low+78.20%
New 52w highYes
SqueezeOff
Bollinger width17.81%
%B0.92
Donchian pos98.42%
Donchian high104.94
Donchian low89.42
AVWAP (52w high)103.99
vs AVWAP high+0.68%
AVWAP (52w low)79.03
vs AVWAP low+32.48%
OBV trendUp
Chaikin MF (20)0.24
Today vs 20d1.63×
Avg vol (14d)9.64M
Avg vol (20d)9.12M
Avg $ vol (20d)893.61M
Market cap133.58B
RS 3m (vs SPY)+27.67%
RS 6m (vs SPY)+23.34%
RS line new highYes
Trend template8/8
Technical rank89.4
1 week+5.58%
1 month+15.39%
3 months+45.05%
6 months+33.61%
1 year+54.92%
YTD+30.66%
P/E75.56
P/B1.72
P/S0.69
P/FCF17.11
EPS1.39
Div yield2.54%
ROE2.28%
ROA0.70%
Debt/Eq0.93
Current0.87
EV/EBITDA21.12
Gross margin14.72%
Net margin0.91%
Rev growth4.95%
EPS growth-61.68%
Price target105.56
Target upside0.83%
Analyst ratingBuy
Institutional98.30%
Ent. value195.71B
Revenue64.55B
Net income2.94B
Gross profit7.33B
Free cash flow7.81B
IndustryRETAIL-DRUG STORES AND PROPRIETARY STORES
ExchangeNYSE
Shares out1.28B
Employees300K
ListedWed, Oct 1, 1952
Free float1.26B
Float %99.3%
Short interest17.76M
Days to cover2.4d
Short volume59.1%
Squeeze score37 / 100
Next earningsThu, Jul 30, 2026 (35d)
EPS forecast$1.86 · 8 est
Last EPS vs est$2.57 vs $2.21
Last surprise+16.3% beat
Setup gradeA+
Conviction93 / 100
Pattern quality—
Tech rank89.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance102.95
Support84.91
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CVS · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 John Boozman senate · R · AR · traded 2026-01-29 | Buy | $1K–$15K | 2026-01-29 | 2026-02-15 | |
 Dwight Evans house · PA · traded 2025-11-21 | Sell | $1K–$15K | 2025-11-21 | 2025-12-05 | |
 Lisa McClain house · MI · traded 2025-10-31 | Sell | $1K–$15K | 2025-10-31 | 2025-11-01 | |
Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
 Adam Smith house · D · WA · traded 2025-08-08 | Sell | $1K–$15K | 2025-08-08 | 2025-08-08 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Sell | $1K–$15K | 2025-05-15 | 2025-05-31 | |
 Julie Johnson house · D · TX · traded 2025-04-01 | Sell | $1K–$15K | 2025-04-01 | 2025-05-14 |
Insider activity
SEC Form 4 transactions in CVS · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Compton-Phillips Amy EVP, Chief Medical Officer · Common Stock · 2026-05-31 | Tax | 7.62K | $693K | 2026-05-31 | 2026-06-01 |
Newman Brian EVP, Chief Financial Officer · Common Stock · 2026-05-31 | Tax | 2.48K | $225K | 2026-05-31 | 2026-06-01 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-21 | Disposition | 1.56K | $146K | 2026-05-21 | 2026-05-22 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-20 | Disposition | 30.44K | $2.9M | 2026-05-20 | 2026-05-22 |
ROBBINS LARRY Director · Cash-Settled Swaps · 2026-05-21 | Sell | 378K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-21 | Sell | 370.46K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 797.63K | $75M | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 800 | $77K | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 66.88K | $6.4M | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 152.69K | $14M | 2026-05-20 | 2026-05-21 |
SEC filings
EDGAR filings in CVS
No recent SEC filings on file for CVS.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.